Search
for

    Glossary Megestrol Acetate

    synthetic progestin used to treat appetite loss and weight loss

    Megestrol Acetate, also known as Megace, is a synthetic progestin used primarily to treat loss of appetite and severe weight loss in patients with cancer or AIDS. It can also be used in the treatment of certain hormone-responsive cancers, such as breast and endometrial cancer, by interfering with hormone activity.

    Sort by

    Research 30 of 68

    1. Megestrol Acetate Increases the Proliferation, Migration, and Adipogenic Differentiation of Adipose-Derived Stem Cells via Glucocorticoid Receptor Stem Cells Translational Medicine · 2015 · 11 citations
    2. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity Urology · 2003 · 228 citations
    3. Problems in evaluating chronic toxicity of contraceptive steroids in dogs Journal of Toxicology and Environmental Health · 1977 · 25 citations
    4. Feline Dermatology Veterinary Clinics of North America: Small Animal Practice · 1984 · 15 citations
    5. P‐41 Psychogenic alopecia by fur‐plucking in a family of seal‐point Siamese cats: three cases Veterinary Dermatology · 2004 · 1 citations
    6. Miscellaneous Exogenous Hormones and Breast Diseases: A Matter of Concern for the Gynecologist Archives of breast cancer · 2019 · 1 citations
    7. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism Journal of Steroid Biochemistry · 1975 · 232 citations
    8. 11 Treatment of hirsutism and acne with cyproterone acetate Clinics in Endocrinology and Metabolism · 1986 · 43 citations
    9. Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i> Gynecological Endocrinology · 2000 · 78 citations
    10. Treatment of androgen excess in females: Yesterday, today and tomorrow Gynecological Endocrinology · 1997 · 9 citations
    11. Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist Drug Research · 2011 · 5 citations
    12. Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail International Journal of Pharmacology · 2025
    13. Assessing medication use patterns among patients with polycystic ovary syndrome at a tertiary care teaching hospital in South Korea: A retrospective study Medicine · 2024
    14. Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells Frontiers in Pharmacology · 2025
    15. PCOS and Obesity: Contraception Challenges Open Access Journal of Contraception · 2025 · 4 citations
    16. A practical approach to feline symmetrical alopecia In Practice · 1998 · 4 citations
    17. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial Fertility and Sterility · 1994 · 165 citations
    18. Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat Gynecological Endocrinology · 1987 · 8 citations
    19. Jenis-jenis Progestin dalam Preparat Kontrasepsi Cermin Dunia Kedokteran · 2024
    20. Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships Current Medicinal Chemistry · 2000 · 204 citations
    21. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients The American Journal of Medicine · 1992 · 116 citations
    22. Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents Annals of Oncology · 2005 · 67 citations
    23. The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications The Prostate · 1986 · 57 citations
    24. Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications* Endocrine reviews · 1984 · 53 citations
    25. Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review International Journal of Dermatology · 2018 · 34 citations
    26. Polycystic ovary syndrome: A review for dermatologists Journal of The American Academy of Dermatology · 2014 · 30 citations
    27. Characteristics of flutamide action on prostatic and testicular functions in the rat Journal of Steroid Biochemistry · 1988 · 30 citations
    28. Androgen antagonists in androgen target tissues Pharmacology & Therapeutics · 1984 · 27 citations
    29. The placebo effect and randomized trials: analysis of conventional medicine Urologic clinics of North America · 2002 · 26 citations
    30. <i>In Vitro</i>and<i>in Vivo</i>Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring Endocrinology · 2005 · 20 citations